BriaCell Therapeutics Corp. BCTX
BCTX
BriaCell Therapeutics Corp. ALZN
Alzamend Neuro, Inc. BCTXW
BriaCell Therapeutics Corp. CNTX
Context Therapeutics Inc. DATS
DatChat, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc PDSB
PDS Biotechnology Corporation VRPX
Virpax Pharmaceuticals, Inc. XFOR
X4 Pharmaceuticals, Inc.
BriaCell Therapeutics Corp. ALZN
Alzamend Neuro, Inc. BCTXW
BriaCell Therapeutics Corp. CNTX
Context Therapeutics Inc. DATS
DatChat, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc PDSB
PDS Biotechnology Corporation VRPX
Virpax Pharmaceuticals, Inc. XFOR
X4 Pharmaceuticals, Inc.
Performance
| Periode | BCTX | ALZN | BCTXW | CNTX | DATS | GRTX | MREO | PDSB | VRPX | XFOR |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -74.13 % | -68.92 % | -24.42 % | 60.40 % | 19.59 % | -40.74 % | 3.95 % | -13.89 % | -91.92 % | -51.71 % |
| YTD | -86.98 % | -79.56 % | -79.61 % | 15.22 % | 45.88 % | -60.10 % | -42.25 % | -46.24 % | -99.78 % | -86.86 % |
| 1Y | -91.56 % | -85.40 % | -82.76 % | -31.10 % | 125.00 % | -76.47 % | -55.82 % | -71.65 % | -99.82 % | -82.29 % |
| 3Y | -98.86 % | -99.84 % | -98.08 % | 25.79 % | -71.90 % | -98.97 % | 97.52 % | -76.69 % | -99.99 % | -95.11 % |
| 5Y | 117 555.86 % | -99.99 % | -92.20 % | -73.12 % | -92.24 % | -99.87 % | -14.13 % | -60.43 % | -100.00 % | -98.54 % |
| 10Y | 65 021 758 357 159 104 001 050 742 358 016.00 % | -99.99 % | -92.20 % | -73.12 % | -92.24 % | -99.87 % | -69.62 % | -99.78 % | -100.00 % | -99.88 % |
| Depuis le début | 1 735 068 912 610.57 % | -99.99 % | -92.20 % | -73.12 % | -92.24 % | -99.87 % | -69.62 % | -99.58 % | -100.00 % | -99.88 % |